These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 10422624

  • 1. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
    Sakakibara M, Abe S, Fusegawa Y, Nakajima T, Iwata O, Goto S, Shiina Y, Handa S.
    J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F, Di Mario C, Catanoso A, Dharmadhikari A, Tzifos V, Anzuini A, Carlino M, Briguori C, Montorfano M, Vaghetti M, Tolaro S, Colombo A.
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.
    Veselka J, Procházková S, Duchonová R, Bolomová-Homolová I, Pálenícková J, Tesar D, Cervinka P, Honek T.
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):231-5. PubMed ID: 15390343
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Alcohol septal ablation through an anomalous right coronary septal perforator: first report and discussion.
    Choi D, Dardano J, Naidu SS.
    J Invasive Cardiol; 2009 Jun; 21(6):e106-9. PubMed ID: 19494415
    [Abstract] [Full Text] [Related]

  • 11. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
    Veselka J.
    Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy.
    Kar S, Makkar R.
    Rev Cardiovasc Med; 2001 Apr; 2(2):97-102. PubMed ID: 12439386
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes.
    Gross CM, Schulz-Menger J, Krämer J, Siegel I, Pilz B, Waigand J, Friedrich MG, Uhlich F, Dietz R.
    J Endovasc Ther; 2004 Dec; 11(6):705-11. PubMed ID: 15615561
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H, Faber L.
    Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy.
    Steendijk P, Meliga E, Valgimigli M, Ten Cate FJ, Serruys PW.
    Heart; 2008 Oct; 94(10):1318-22. PubMed ID: 18450844
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.